The Stress Eater

Leanne age 43

“I wish I could be carefree and just enjoy life. But with my weight being an issue on top of all the things I’m juggling, I’m often stressed out and frustrated.”

Is Mysimba® right for Leanne?

Not an actual patient.

Actor portrayal of the stress eater potentially indicated for Mysimba®.

Medical Background

  • BMI of 34
  • Weight has been stable over the last year
  • Diet and overall health are less than optimal

Weight-loss History

  • Has recently managed to keep her weight stable by prioritizing healthier meals but often resorts to fast food to deal with her stress
  • Recognizes eating behavior is not completely within her control but does not know how to suppress her cravings
  • Seeks a weight-loss solution that gives her the structure she needs and fits into her life

Lifestyle and Beliefs

  • Single, working mom of 3 kids with limited free time
  • Tends to eat when she is stressed, worried, or sad, which is often
  • Wakes up early to get the kids to school and often has to catch up on work after their bedtime
  • Admits that her family obligations are her highest priority and are key barriers to focusing on weight loss

Use Mysimba® to enhance those efforts for patients like Leanne who are seeking a prescription treatment.1,2,3

View dosing information

BMI=body mass index.

References:

  1. Mysimba® (naltrexone HCI and bupropion HCI) [prescribing information]. Brentwood, TN: Nalpropion Pharmaceuticals LLC; 2021.
  2. Data on file. Currax Pharmaceuticals LLC. Brentwood, TN; 2019
  3. Greenway FL, Fujioka K, Plodkowski RA, et al. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2010;376(9741):595-605
Reporting adverse effects: Adverse effects should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store. Alternatively you can report a suspected adverse drug reaction to the Yellow Card scheme by calling 0800 731 6789 Adverse events should also be reported to Orexigen®: +44 20 3966 0116 or currax.mi@primevigilance.com.
Important Safety Information

Please refer to the Mysimba® Summary of Product Characteristics (SmPC)


▼ Black Triangle

This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.

MYS 014
Important Safety Information

Please refer to the Mysimba® Summary of Product Characteristics (SmPC)


▼ Black Triangle

This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.

MYS 014
Important Safety Information

Please refer to the Mysimba® Summary of Product Characteristics (SmPC)


▼ Black Triangle

This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.

MYS 014